HRSA-21-116: American Rescue Plan—Funding for Native Hawaiian Health Care (ARP-NH)
Closed
This grant is closed. A newer notice from the same program is forecast: Native Hawaiian Health Care Improvement Act Program (HRSA-27-013). Status: Expected deadline April 12, 2027. It is in our archive of Health Resources and Services Administration notices from 2021.
Health Resources and Services Administration offered grants to the applicants described in the notice. It expected to make about 6 awards worth $20.0 million in total. Applications closed on July 2, 2021.
From the official notice on Grants.gov, last changed June 2, 2021. Checked November 7, 2026.
- Total funding$20.0 million
- Expected awards6
- Cost sharingNot required
- Funding typeGrant
Key dates
| Posted | June 2, 2021 |
|---|---|
| Deadline | July 2, 2021 |
| Archived by Grants.gov | August 31, 2021 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
ARP-NH funding is available to current NHHCIA award recipients as listed in Table 1.
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
This notice announces the opportunity for Native Hawaiian Health Care Improvement Act (NHHCIA) current award recipients to apply for one-time funding under the fiscal year (FY) 2021 American Rescue Plan—Funding for Native Hawaiian Health Care (ARP-NH). The purpose of this funding is to provide support for current NHHCIA award recipients to respond to and mitigate the spread of COVID-19, and to enhance health care services and infrastructure. The authority for this program is the Native Hawaiian Health Care Improvement Act, as amended (42 U.S.C. §11701-11714); and Section 2601, American Rescue Plan Act of 2021 (P.L. 117-2). Funding for this award is appropriated by Section 2601 of the American Rescue Plan Act of 2021 (P.L. 117-2), available at https://www.congress.gov/117/bills/hr1319/BILLS-117hr1319enr.pdf.
Who has won Native Hawaiian Health Care Systems grants before
From fiscal 2021 to 2025, Native Hawaiian Health Care Systems (93.932) awarded $137 million across 22 grant awards, an average of $6.2 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Papa Ola Lokahi | Hawaii | 3 | $42.1 million |
| Ho-Ola Lahui Hawaii Inc | Hawaii | 2 | $19.3 million |
| Hui No Ke Ola Pono Inc | Hawaii | 2 | $19.3 million |
| Hui Malama Ola NA 'Oiwi | Hawaii | 2 | $18.6 million |
| Ke Ola Mamo | Hawaii | 2 | $17.5 million |
Applying now
This notice no longer takes applications. Apply under the newer notice, HRSA-27-013, which is forecast.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is HRSA-21-116 still open?
No. It closed on July 2, 2021. A newer notice is forecast: HRSA-27-013, expected deadline April 12, 2027.
Who can apply for American Rescue Plan—Funding for Native Hawaiian Health Care (ARP-NH)?
Health Resources and Services Administration accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for American Rescue Plan—Funding for Native Hawaiian Health Care (ARP-NH)?
Closed July 2, 2021. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
About $20.0 million in total across about 6 awards.
Who has won Native Hawaiian Health Care Systems grants before?
The largest recipients over five fiscal years were Papa Ola Lokahi, Ho-Ola Lahui Hawaii Inc, Hui No Ke Ola Pono Inc. The program made 22 awards worth $137 million in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)